Loss of transcription factor EB dysregulates the G1/S transition and DNA replication in mammary epithelial cells

Logan Slade1, Dipsikha Biswas1, Petra C Kienesberger1

  • 1Department of Biochemistry and Molecular Biology, Dalhousie University, Dalhousie Medicine New Brunswick, Saint John, New Brunswick, Canada.

Insights

Transcription factor EB (TFEB) is crucial for triple-negative breast cancer (TNBC) survival by controlling DNA replication and cell cycle progression. Inhibiting TFEB impairs TNBC cell proliferation and increases sensitivity to Aurora Kinase A inhibitors.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Triple-negative breast cancer (TNBC) presents treatment challenges due to a lack of targeted therapies and high relapse rates.
  • Transcription factor EB (TFEB) has been identified as essential for TNBC survival, regulating DNA repair, apoptosis, and cell cycle pathways.
  • The precise mechanisms by which TFEB influences DNA repair and cell cycle, and their impact on TNBC survival, remain unclear.

Purpose of the Study:

  • To elucidate the specific mechanisms through which TFEB regulates DNA repair and cell cycle pathways in TNBC.
  • To determine if TFEB's effects on these pathways are critical for TNBC cell survival.
  • To investigate the therapeutic potential of targeting TFEB in TNBC.

Main Methods:

  • TFEB knockdown was performed in MDA-MB-231 TNBC cells and MCF10A noncancerous cells.
  • Gene and protein expression related to DNA replication and cell cycle were analyzed.
  • DNA replication was measured using EdU incorporation.
  • Cell cycle progression was assessed after G1/S synchronization.
  • Origin licensing was evaluated in G1 and early S-phase cells.
  • Sensitivity to Aurora Kinase A inhibitors was tested.

Main Results:

  • TFEB knockdown decreased expression of genes and proteins involved in DNA replication and cell cycle progression in TNBC cells.
  • TFEB silencing reduced DNA replication and impaired G1/S phase transition.
  • TFEB knockdown reduced origin licensing in G1 and early S-phase MDA-MB-231 cells.
  • TFEB silencing led to replication stress and G1/S arrest in noncancerous MCF10A cells, but not in TNBC cells.
  • TFEB knockdown sensitized TNBC cells to Aurora Kinase A inhibitors, decreasing cell viability.

Conclusions:

  • TFEB inhibition disrupts cell cycle progression in TNBC by reducing origin licensing and delaying S-phase entry.
  • Targeting TFEB enhances the sensitivity of TNBC cells to Aurora Kinase A inhibitors, offering a potential therapeutic strategy.
  • TFEB silencing has differential effects on cancer and noncancerous cells, causing replication stress and G1/S arrest in the latter.

Related Concept Videos

Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.5K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
3.1K
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
7.0K
DNA Damage can Stall the Cell Cycle02:37

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.3K
Transcription Factors02:16

Transcription Factors

Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
76.3K